The Pharmacy Times® Brain Health Resource Center is a comprehensive resource for clinical news and expert insights on issues related to neural development, plasticity, functioning, and recovery associated with aging.
June 11th 2025
Taletrectinib demonstrated high response rates and was well tolerated among patients with ROS1+ non-small cell lung cancer (NSCLC).